Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;40(3):556-560.
doi: 10.1002/mds.30054. Epub 2024 Nov 12.

Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome-Wide Association Study

Affiliations

Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome-Wide Association Study

Yujia Zhao et al. Mov Disord. 2025 Mar.

Abstract

Background: Alterations in gut microbiota are observed in Parkinson's disease (PD). Previous studies on microbiota-derived metabolites in PD were small-scale and post-diagnosis, raising concerns about reverse causality.

Objectives: Our goal was to prospectively investigate the association between plasma microbial metabolites and PD risk within a metabolomics framework.

Methods: A nested case-control study within the prospective EPIC4PD cohort, measured pre-diagnostic plasma microbial metabolites using untargeted metabolomics.

Results: Thirteen microbial metabolites were identified nominally associated with PD risk (P-value < 0.05), including amino acids, bile acid, indoles, and hydroxy acid, although none remained significant after multiple testing correction. Three pathways were implicated in PD risk: valine, leucine, and isoleucine degradation, butanoate metabolism, and propanoate metabolism. PD-associated microbial pathways were more pronounced in men, smokers, and overweight/obese individuals.

Conclusion: Changes in microbial metabolites may represent a pre-diagnostic feature of PD. We observed biologically plausible associations between microbial pathways and PD, potentially influenced by individual characteristics. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keywords: gut‐brain axis; microbial metabolites; Parkinson's disease; pre‐diagnostic biosamples; untargeted metabolomics.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Microbiota‐relevant pathways associated with Parkinson's disease (PD) in the main analyses and stratified analyses. Pathways enriched with PD‐associated metabolic features were identified using MetaboAnalyst 5.0. The position of the dot on the x‐axis corresponds to the −log10 P‐value calculated for the pathway, and the size of the dot corresponds to the number of features meeting P‐value <0.05 in the pathway. [Color figure can be viewed at wileyonlinelibrary.com]

References

    1. Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha‐synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease‐related brain pathology. Neurosci Lett 2006;396(1):67–72. - PubMed
    1. Zierer J, Jackson MA, Kastenmuller G, et al. The fecal metabolome as a functional readout of the gut microbiome. Nat Genet 2018;50(6):790–795. - PMC - PubMed
    1. Neveu V, Nicolas G, Amara A, Salek RM, Scalbert A. The human microbial exposome: expanding the exposome‐explorer database with gut microbial metabolites. Sci Rep 2023;13(1):1946. - PMC - PubMed
    1. Chen SJ, Chen CC, Liao HY, et al. Association of fecal and plasma levels of short‐chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease. Neurology 2022;98(8):e848–e858. - PMC - PubMed
    1. Shao Y, Li T, Liu Z, et al. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography‐mass spectrometry. Mol Neurodegener 2021;16(1):4. - PMC - PubMed